Alafair Bioscience Reports the US FDA Approval of VersaWrap
Shots:
- Alafair Biosciences receives 510(k) clearance from the US FDA for VersaWrap which allows for the application of VersaWrap in all populations, irrespective of age incl. pediatric cases
- This clearance provides pediatric surgeons with increased flexibility in utilizing VersaWrap for treating a range of conditions in younger populations. It addresses congenital abnormalities, fractures, and injuries, potentially improving postoperative outcomes in pediatric surgery.
- VersaWrap, a class II medical device, is a bioresorbable hydrogel that forms a gel layer around tissues, facilitating smooth healing, reducing postoperative tethering, & ensuring consistent results in tendon and peripheral nerve procedures
Ref: PR Newswire | Image: Alafair Bioscience
Related News:- GE Healthcare Received the US FDA’s 510(k) for New Version of Digital Expert Access & collaborates with IONIC Health
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Kritika is a content writer at PharmaShots. She is interested in covering recent innovations from the pharma & MedTech industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
